Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMpARE: Colchicine PK in Gout Flare
NCT03933007Phase 4Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Sep 2019
- Primary completion
- Oct 2019
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of colchicine in acute gouty arthritis, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Maximum plasma concentration of colchicine. Started Sep 2019; status: terminated.
02
Drugs
colchicine
03
Conditions
acute gouty arthritis
Beyond the preview
Go deeper on NCT03933007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03933007.